Job opportunity
 Although we are currently not advertising for any open job positions at the SNP&SEQ Technology Platform you are welcome to send a spontaneous application (CV + personal letter) to:
ann-christine.syvanen@medsci.uu.se.
 We are constantly looking for experienced and skilled research engineers and bioinformaticians.

SNP Methods and References

 

The SNP&SEQ Technology Platform is equipped for genotyping projects with one or a few SNPs to hundreds of thousands of SNPs in 100 - 10,000 of samples (Syvänen 1999; Syvänen 2001; Syvänen 2005). Our genotyping systems are based on primer extension technology with fluorescence detection. The reaction principles underlying the genotyping systems are described below. Click on the system of interest to read more, or contact us to discuss the most suitable method for your project.

  • Whole-genome genotyping using the Illumina Infinium assay
    Sets of SNPs are available in human, domestic animals and crops ranging from custom sets of 6,000 SNPs to fixed sets of 5,000,000 SNPs to be genotyped for each individual sample. Appropriate for disease association studies, QTL analysis as well as for detecting copy number variation and loss of heterozygosity. Using the HumanMethylation450 array, methylation changes can be detected in more than 480,000 CpG sites in the human genome. It covers 99% of RefSeq genes, with an average of 17 CpG sites per gene region distributed across the promoter, 5'UTR, first exon, gene body, and 3'UTR.
  • Highly multiplexed SNP genotyping using the Illumina GoldenGate assay
    Custom SNP panels with 48-3072 SNPs are most commonly used. In addition, fixed panels specific for cancer genetics, or linkage studies in human or mice are available.
  • Single SNP analysis with fluorescence polarisation
    Used for genotyping of individual SNPs, suitable for large sets of samples.



References
-Syvänen AC (1999) From gels to chips:"minisequencing" primer extension for analysis of point mutations and single nucleotide polymorphisms. Hum Mutat 13:1-10
-Syvänen AC (2001) Accessing genetic variation: genotyping single nucleotide polymorphisms. Nat Rev Genet 2:930-942
-Syvänen AC (2005) Toward genome-wide SNP genotyping. Nat Genet 37 Suppl:S5-10

 

News

  • MolMed receives new grant

    2012-04-23

    Large grant for epigenetic and genomic analyses of the brain from VR, FAS, Formas and Vinnova to Molecular Medicine and the SNP&SEQ platform.

  • New sequencer, MiSeq

    2012-03-16

    The SNP&SEQ Technology Platform has installed a MiSeq instrument from Illumina.

  • The Swedish Childhood Cancer Foundation

    2011-12-14

    Molecular Medicine research group has received funding from the Swedish Childhood Cancer Foundation.

  • VR grant

    2011-11-17

    VR-RFI has granted 6.7 million SEK for running costs to the SNP&SEQ platform.

  • K&A Wallenberg grant

    2011-10-04

    Molecular Medicine research group has received funding from the K&A Wallenberg foundation.

  • Publication in Nature

    2011-08-11

    A study that doubles the number of susceptibility genes for multiple sclerosis (MS) was published in Nature on Aug 11.

  • Instrument Upgrade.

    2011-06-20

    The SNP&SEQ Technology Platform have now upgraded our Genome Analyzer IIx with a HiSeq 2000 instrument from Illumina.

  • Publication in Nature Genetics

    2011-03-06

    Five new loci for coronary artery disease were published on-line in Nature Genetics on March 6th.

  • European Project: ESGI

    2011-01-18

    The Molecular Medicine group contributes to the ESGI infra-structure by technology development, eg. allele-specific gene expression and epigenetics.